within Pharmacolibrary.Drugs.ATC.J;

model J01DB06
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 8.333333333333333e-05,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>J01DB06</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cefazedone is a first-generation cephalosporin antibiotic formerly used for the treatment of bacterial infections, particularly those caused by Gram-positive organisms. Its clinical use has fallen out of favor and it is not widely approved or used today.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical adult, as no directly reported PK studies or publications with population PK data were found.</p><h4>References</h4><ol><li><p>Gao, L, et al., &amp; Wei, MJ (2015). A Pharmacokinetic and Pharmacodynamic Study on Intravenous Cefazedone Sodium in Patients with Community-acquired Pneumonia. <i>Chinese medical journal</i> 128(9) 1160–1164. DOI:<a href=&quot;https://doi.org/10.4103/0366-6999.156086&quot;>10.4103/0366-6999.156086</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25947397/&quot;>https://pubmed.ncbi.nlm.nih.gov/25947397</a></p></li><li><p>Pabst, J, et al., &amp; Dingeldein, E (1979). Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. II. Pharmacokinetics in comparison with cefazolin. <i>Arzneimittel-Forschung</i> 29(2a) 437–443. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/582722/&quot;>https://pubmed.ncbi.nlm.nih.gov/582722</a></p></li><li><p>Cui, Y, et al., &amp; Bi, K (2014). Development of an ultra fast liquid chromatography-tandem mass spectrometry method for simultaneous determination of cefazedone and etimicin in beagle dog plasma: Application to the pharmacokinetic study of the combination of cefazedone and etimicin injections. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 973C 97–103. DOI:<a href=&quot;https://doi.org/10.1016/j.jchromb.2014.10.018&quot;>10.1016/j.jchromb.2014.10.018</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25464101/&quot;>https://pubmed.ncbi.nlm.nih.gov/25464101</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end J01DB06;
